A machine learning framework combining cfDNA fragmentomics and serum…
A combined blood test merging DNA fragments and protein markers detects ovarian cancer with 97% accuracy, potentially improving screening and pre-surgery planning.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Single-cell imaging analysis, therapeutic modeling and a Phase Ib…
Researchers identified a shared cancer vulnerability across prostate-cancer subtypes and showed early promise combining two drugs to reduce tumor cells in blood.
Near-term implementable findingIn-Hospital Initiation of SGLT2 Inhibitors in Patients with Acute Heart Failure
Starting a diabetes drug during heart-failure hospitalization cuts death risk by 39% and serious worsening by 33%, offering an immediately adoptable treatment approach.
Standard additionCD135 (FLT3 receptor) expression as an indicator of prognosis in…
A blood marker predicts which acute leukemia patients respond poorly to standard treatment and may benefit from targeted therapy combinations.
Near-term implementable findingPrognostic Modeling Based on Post-Endovascular Thrombectomy Systolic…
An AI model using blood-pressure patterns after stroke treatment better predicts recovery than traditional clinical measures, guiding smarter BP management.